Technologies / CookieYes
CookieYes
243 companies recorded in CookieYes, page 1 of 3.
| Company | Country | Stage | Raised |
|---|---|---|---|
| 2 CIRCLE, INCORPORATED | US | unknown | $2.0M |
| Abound | GB | series-b+ | $400.1M |
| Actithera | NO | series-a | $86.4M |
| ACTIVE LIFE SCIENTIFIC INC | US | unknown | $2.9M |
| AcuityMD | US | series-b+ | $150.0M |
| AD HOC RESEARCH ASSOCIATES LLC | US | unknown | $2.0M |
| Adaptional | US | seed | $10.1M |
| Adaptive ML | US | series-a | $20.0M |
| ADVANCED COOLING TECHNOLOGIES INC | US | unknown | $1.6M |
| ADVR, INC. | US | unknown | $1.2M |
| Agaton | SE | seed | $10.8M |
| Aiden | DE | seed | $1.0M |
| AiPrise | US | series-a | $17.0M |
| AIQ GLOBAL INC | US | unknown | $2.0M |
| AIRBORNE OUTFITTERS LLC | US | unknown | $1.5M |
| Aktiia | CH | series-b+ | $95.0M |
| Alice & Bob | FR | series-b+ | $137.2M |
| ALIDA BIOSCIENCES INC. | US | unknown | $2.2M |
| Apmonia Therapeutics | FR | unknown | $7.6M |
| Aqua Voice | US | seed | $1.0M |
| Aracor AI | US | pre-seed | $4.5M |
| ARCHEM, LLC | US | unknown | $2.0M |
| ARQ | US | series-a | $1.0M |
| Ascendx | GB | series-b+ | $110.0M |
| Ashby | US | series-a | $5.0M |
| Asher Bio | US | series-a | $5.0M |
| Astrolight | LT | seed | $3.0M |
| Astut | GB | seed | $1.9M |
| Atavistik Bio | US | series-b+ | $220.0M |
| Attestiv | US | unknown | $1.0M |
| Augmetec | GB | seed | $2.6M |
| AutonomyAI | US | pre-seed | $4.0M |
| Avelios Medical | DE | series-a | $32.4M |
| Baya Systems | US | series-b+ | $75.0M |
| Believ | GB | series-b+ | $381.0M |
| BeyondMath | GB | seed | $9.1M |
| BIOMASON INC. | US | unknown | $1.9M |
| BIOMEDINNOVATIONS LLC | US | unknown | $3.5M |
| Bonum Therapeutics, Inc. | US | unknown | $26.9M |
| BootLoop | US | seed | $1.0M |
| bunch | DE | series-a | $15.3M |
| CamGraPhic | GB | series-a | $27.0M |
| Candela | SE | series-b+ | $216.0M |
| Capital on Tap | GB | series-b+ | $635.0M |
| CarbonX | NL | unknown | $2.7M |
| CarbonX | NL | unknown | $2.7M |
| Cardo AI | IT | series-a | $20.0M |
| Career Allies, Inc | US | unknown | $18.4M |
| CellCentric | GB | series-b+ | $300.0M |
| Certus AI | US | seed | $1.0M |
| Cognida.ai | US | series-a | $15.0M |
| Covera Health, Inc. | US | unknown | $21.4M |
| Cresilon | US | unknown | $5.0M |
| Crossover Markets | US | series-a | $12.0M |
| CSignum | GB | series-a | $10.8M |
| CUbIQ Technologies | NL | unknown | $2.7M |
| CueZen Inc. | US | unknown | $5.2M |
| Dash Bio, Inc | US | unknown | $11.0M |
| Dash Bio, Inc. | US | unknown | $11.0M |
| Decart | US | series-b+ | $100.0M |
| DeepJudge | CH | series-a | $39.0M |
| Defense Unicorns | US | series-b+ | $190.0M |
| Desia | IT | unknown | $3.1M |
| DualEntry | US | series-a | $110.0M |
| Duke Street Bio | US | unknown | $4.1M |
| Electra Therapeutics, Inc | US | unknown | $134.2M |
| Elemental Machines, Inc. | US | unknown | $5.7M |
| Ember | US | seed | $70.6M |
| EMPOWER EQUITY INC | US | unknown | $2.0M |
| Endor Labs | US | series-b+ | $93.0M |
| EnduroSat | BG | unknown | $147.0M |
| Enifer | FI | series-b+ | $38.9M |
| Eoliann | IT | seed | $4.6M |
| Espresa, Inc. | US | unknown | $5.0M |
| ETEGENT TECHNOLOGIES, LTD. | US | unknown | $1.2M |
| Ethermed | US | series-a | $8.5M |
| EthonAI | CH | series-a | $18.1M |
| Exotec | FR | series-b+ | $450.0M |
| Fathom | US | series-a | $5.0M |
| Filed | SE | seed | $17.0M |
| finQbit | PL | unknown | $540,000 |
| Finzly | US | unknown | $6.0M |
| FireHUD, Inc. | US | unknown | $1.3M |
| Flint | US | series-a | $19.0M |
| Formo | DE | series-b+ | $95.0M |
| FoRx Therapeutics | CH | series-a | $46.1M |
| Foundation Alloy Technology Explorations, Inc. | US | unknown | $20.0M |
| FYCH Technologies | ES | series-a | $6.0M |
| Galtea | ES | seed | $4.1M |
| Gather Health | US | series-a | $1.0M |
| GENNEXT TECHNOLOGIES, INC. | US | unknown | $2.5M |
| GEVI | IT | seed | $2.9M |
| Glitch | IE | seed | $2.8M |
| Glydways | US | series-b+ | $203.0M |
| GR3N | CH | series-b+ | $16.7M |
| Great Question | US | series-a | $5.0M |
| Greenboard | US | seed | $1.0M |
| Gridware | US | series-b+ | $93.0M |
| H1 Insights, Inc. | US | unknown | $95.0M |
| Healthera | GB | series-a | $7.1M |